The guideline has not sought to define acceptable CS rates. Rather the purpose of this guideline is to enable healthcare professionals to give appropriate research-based advice to women and their families. This will enable women to make properly informed decisions. Caesarean section (CG132). The guideline will assume that prescribers will use a drug's summary of product characteristics to inform decisions made with individual patients